Emergent Biosolutions Inc (EBS) returns
Emergent Biosolutions returns over 10 years
$1,000 invested in Emergent Biosolutions ten years ago was worth $253.16 at the close on October 30, 2026, with dividends reinvested: an average return of -12.8% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +3.2% | — | $1,032 | -0.9% |
| 3 months | -6.2% | — | $938.02 | +2.1% |
| Year to date | -44.9% | — | $550.97 | +11.7% |
| 1 year | -47.0% | — | $530.37 | +12.4% |
| 3 years | +235.5% | +49.7% | $3,355 | +88.5% |
| 5 years | -85.7% | -32.2% | $142.86 | +76.0% |
| 10 years | -74.7% | -12.8% | $253.16 | +316.6% |
Emergent Biosolutions return by calendar year
| Year | EBS | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -44.9% | +11.7% | -56.6% |
| 2025 | +29.3% | +17.7% | +11.6% |
| 2024 | +298.3% | +24.9% | +273.4% |
| 2023 | -79.7% | +26.2% | -105.9% |
| 2022 | -72.8% | -18.2% | -54.7% |
| 2021 | -51.5% | +28.7% | -80.2% |
| 2020 | +66.1% | +18.4% | +47.7% |
| 2019 | -9.0% | +31.2% | -40.2% |
| 2018 | +27.6% | -4.6% | +32.1% |
| 2017 | +41.5% | +21.7% | +19.8% |
| 2016 | -13.0% | +12.0% | -25.0% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: EBS financials · EBS valuation
No forecast, no recommendation. This page describes Emergent Biosolutions Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.